Navigation Links
Isis Pharmaceuticals Reports Positive Phase 1 Data Demonstrating ISIS-APO(a) Rx Produces Significant Reductions in Lp(a) Levels
Date:11/16/2013

ttp://www.isispharm.com/">www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT
This press release includes forward-looking statements regarding the discovery, development, activity, therapeutic potential and safety of ISIS-APO(a)Rx.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2012, and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
2. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
3. ANI Pharmaceuticals To Present At Oppenheimer 24th Annual Healthcare Conference On December 10, 2013
4. Ampio Pharmaceuticals to Present at Upcoming Investor Conference
5. DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
6. Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results
7. Isis Pharmaceuticals Earns $1.5M from the Advancement of the Phase 2 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
8. Actinium Pharmaceuticals Appoints Richard Steinhart As New Independent Director
9. Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results
10. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Third Quarter Financial Results
11. GW Pharmaceuticals to Report 2013 Q4 and Full Year Financial Results and Host Conference Call on 19 November, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... New York , July 27, 2015 ... Market Research "Bionics Market - Global Industry Analysis, Size, Share, ... was valued at USD 7.96 billion in 2014, growing at ... for USD 20.49 billion in 2021. The global ... the number of accidents, which is leading to paralysis or ...
(Date:7/27/2015)... CITY , July 27, 2015 Dynatronics Corporation (NASDAQ: ... for its Solaris therapeutic modality products. This approval allows the company ... many other countries around the world. "Receiving the CE ... sales efforts," stated Kelvyn H. Cullimore Jr. , president and ... our distribution network into China , ...
(Date:7/27/2015)... -- Bloomage BioTechnology Corporation Limited ("Bloomage" or "The Company", ... South Korean BioTech Company Medytox Inc. ("Medytox", Stock Code: ... and promote Type A Botulinum Toxin ("Botulinum Toxin") business ... Medytox, the Botulinum Toxin brand, occupies the highest market ... in the world successfully developed and produced Botulinum Toxin, ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Dynatronics Awarded CE Mark Approval for Its Solaris Products 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3
... Oramed Pharmaceuticals,Inc. (OTCBB: ORMP) ( http://www.oramed.com ), a developer ... a conference call on August 6,2008 at 10:30 AM ... clinical trials,of its flagship product, ORMD 0801, an oral ... on assessing the safety and efficacy,of ORMD 0801. This ...
... Drugs Extends Lifespan Three Years in,Alzheimer,s -, ... three potential Alzheimer,s therapies raise hope for new ... reported today at the,2008 Alzheimer,s Association International Conference ... related study showed that taking antidementia drugs appears ...
Cached Medicine Technology:Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials 2Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 2Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 3Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 4Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 5Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 6Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 7Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 8Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 9
(Date:7/27/2015)... ... July 27, 2015 , ... In a piece published ... side of plastic surgery and explained why people should not shy away from their ... the excesses of the few and celebrate it for the modern wonder that it ...
(Date:7/27/2015)... ... 2015 , ... The Maricopa Community Colleges today announced a new ... to get into and complete college. , The “Bridging Success Initiative,” funded by ... with partners from across the valley. , The initiative advisory board has representatives from ...
(Date:7/27/2015)... ... July 27, 2015 , ... In an ... hiking to its options. Already an industry leader because of its use ... lookout for the latest successful trends in helping people to overcome addiction and ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they ... that tooth loss can incur a lot of stress, pain, discomfort and embarrassment, which ... The All-On-4™ treatment reaps the benefits of implants with the cost savings of ...
(Date:7/27/2015)... ... 2015 , ... Hexagon Geospatial is pleased to introduce the ... your geospatial experience. These new light-weight applications cohesively combine data, workflows, and analytics. ... “Our world is more dynamic than it has ever been,” said Mladen Stojic, ...
Breaking Medicine News(10 mins):Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 3Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3
... The schools in the US appear to be suffering from ... single nurse only. There are about 56,000 nurses working across ... to one nurse for every 950 students, while the federal ... nurse to student ratio is the worst in Utah, when ...
... acquitted on Wednesday of murdering three of his patients with ... a retired army officer from North Wales, was found not ... of three seriously ill men, after a six-week trial. No ... the deaths of other patients under the care of Dr ...
... The vice president of Sandia National Laboratories, Gerry Yonas was the ... ,This led to the development of the BiNational Sustainability ... at Santa Teresa. This will mainly augment the border security ... Canada & Mexico. ,The monetary inputs for ...
... community medicine and colleagues developed the latest tool for identifying ... tool which is called the Newest vital sign. It is ... an ice cream nutrition label. Based on the number of ... be calculated. , Then it is for the ...
... gobbi and his team from Universite de Montreal ... the level of endocannabinoids by blocking the degradation ... chemicals present in brain which is responsible for ... receptors are triggered during exercises and other well-being ...
... the Annals of Internal Medicine this week have found ... the verge of kidney failure is useless. //The study ... in London, Canada found that a treatment called "plasma ... ,This means that the money which is ...
Cached Medicine News:Health News:School Children Put To Risk Due To Shortage Of Nurses 2Health News:British Doctor cleared of murder 2
... is a collarless flat wedge-shaped implant ... in a design that is relatively ... incorporation of standard and lateralized offset ... to reconstruct a stable joint with ...
Build your Basic Small Joint Set from the suggested instruments or select other insruments for the set....
Supplemental instrument to the Small Joint Arthroplasty System....
... The HUNTER Active & Passive Tendon ... one or the two-stage procedure developed by ... of flexor and extensor tendons in individuals ... intended to be implanted temporarily in order ...
Medicine Products: